The CardBoard
Some early monoclonal antibody results - Printable Version

+- The CardBoard (https://thecardboard.org/board)
+-- Forum: Emergency (https://thecardboard.org/board/forum-11.html)
+--- Forum: Covid-19 (https://thecardboard.org/board/forum-12.html)
+--- Thread: Some early monoclonal antibody results (/thread-20450.html)

Pages: 1 2


RE: Some early monoclonal antibody results - dabigv13 - 12-18-2020

To run infusion clinics for these mAbs you need space and nurses. Hard to come by right now.


RE: Some early monoclonal antibody results - BostonCard - 12-18-2020

Here's the New England Journal article:

https://www.nejm.org/doi/full/10.1056/NEJMoa2035002?query=RP

Quote:In the overall trial population, 6% of the patients in the placebo group and 3% of the patients in the combined REGN-COV2 dose groups reported at least one medically attended visit; among patients who were serum antibody–negative at baseline, the corresponding percentages were 15% and 6% (difference, −9 percentage points; 95% CI, −29 to 11).

The paper only reports "medically attended visit" as an endpoint, and I would guess that hospitalization is a small subset of that.  With a 3% absolute risk difference, you would have to treat 30 patients to prevent one "medically attended visit".

BC


RE: Some early monoclonal antibody results - M T - 12-18-2020

Absolutely yes.  This is what I was trying to get for my relative who got the false positive.  

The sluggishness of the facility ("No, I can't pass a message to the doctor.  No, the administrator doesn't work on the weekends.") was a big impediment for this.  The 3-day delay in getting the PCR test back was almost too long for the "within 3 days of first symptoms" for the drug. 

For my other relative who actually did get COVID, the 3 days to get the test results back made it already too late because she had symptoms before the test.


RE: Some early monoclonal antibody results - Goose - 12-20-2020

https://www.nbcnews.com/health/health-news/godsend-or-not-worth-effort-monoclonal-antibodies-divide-overwhelmed-covid-n1251684

Covers the pros and cons. It will be interesting to see the clinical trial results as they become available.